Of note, to better explore LEVs markers, we demonstrate tetraspanin labelling (CD9, CD63 and CD81) in our LEVs isolates from pooled plasma samples from nevi and melanoma patients (Supplementary Figure S3). This evidence concerns the gene CD81 and melanoma.